雾化吸入抗结核药物治疗重症肺结核的临床效果

目的探讨雾化吸入抗结核药物治疗重症肺结核的临床效果,为进一步对做好肺结核治疗的工作提供科学依据。方法以104例雾化吸入抗结核药物治疗重症肺结核患者为研究对象,将患者随机分为两组,通过对患者采用针对性治疗与观察,采用回顾性方法研究分析临床资料。结果雾化治疗组临床预后有效率为91.67%,常规组有效率为73.21%,雾化组肺结核患者临床预后效果明显好于常规组(P<0.05)。结论雾化吸入抗结核药物治疗重症肺结核具有较好临床疗效,可以明显改善和缓解患者临床症状。

The clinical effect of aerosol inhalation of anti-TB drug treatment of severe tuberculosis

Objective To investigate the clinical effects of aerosol inhalation of anti-TB drug treatment of severe pulmonary tuberculosis,in order to further the work of the good tuberculosis treatment to provide a scientific basis.Methods 104 cases of aerosol inhalation of anti-TB drug treatment of severe pulmonary tuberculosis patients were randomly divided into two groups,through targeted therapy in patients with a retrospective method of analysis of clinical data.Results Atomization treatment group clinical outcomes effective rate of 91.67%,the conventional group was 73.21%,atomized group of tuberculosis patients with clinical prognosis is obviously better than the conventional group(P <0.05).Conclusion The aerosol inhalation anti-TB drugs treatment of severe pulmonary tuberculosis with better clinical efficacy,significant improvement and remission in patients with clinical symptoms.